Soft Exosuit Market

Soft Exosuit Market Outlook 2025 to 2035

The global soft exosuit market is expected to reach USD 1,175 Million by 2035, up from USD 283 Million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 15.3%.

The rising demand of the high level of mobility solutions to the neurological and physical impairment such as stroke recovery, spinal injuries and muscular disorders leads to the market of the soft exosuit. The growing elderly demographics are driving the demand of supportive aids that will improve autonomy and quality life. The fact that soft-textile based suits are more comfortable and flexible than the rigid systems is also supporting adoption, and continuous development of robotics, sensors, AI is turning devices smarter, lighter and less expensive.

Quick Stats for Soft Exosuit Market

• Industry Value (2025): USD 283 Million
• Projected Value (2035): USD 1,175 Million
• Forecast CAGR (2025 to 2035): 15.3%
• Leading Segment (2025): Lower Body (64.80% Market Share)
• Fastest Growing Country (2025-2035): Japan (15.3% CAGR)
• Top Key Players: SuitX (Ottobock), ReWalk Robotics Ltd., Ekso Bionics Holdings Inc., CYBERDYNE Inc., Myomo Inc., B-Temia, Bioservo Technologies AB, ExoAtlet, and Wearable Robotics Srl

What are the drivers of the Soft Exosuit Market?

The market of soft exosuit is growing because the companies are concentrating on light and textile-based wearable products that can support rehabilitation, mobility and comfort of the patients. The increases in the rates of neurological disorders, injuries to the spinal cord and stroke recovery are increasing the need of effective assistive devices. The ageing demographic is now demanding mobility support solutions that enhance independence and quality of life and hospitals/ rehabilitation centers are now incorporating exosuits as part of the therapy programs.

The innovations in the field of robotics, sensors, and AI contribute to the market adoption by making the devices more flexible and tailored. Favorable healthcare funding, reimbursement programs and increased awareness of rehabilitation technologies are other factors that enhance the development across the world.

What are the regional trends of the Soft Exosuit Market?

The healthcare-oriented soft exosuit market presents the regional dynamics, which are determined by the demographics, healthcare facilities, and rehabilitation requirements. The North America region is the most progressive in adoption as it has well-developed healthcare systems, is deeply invested in rehabilitation technology, and is particularly interested in the elderly mobility solutions.

Strong aging populations and favorable healthcare financing of assistive devices are reaping benefits to Europe with such countries as Germany, Sweden, and the UK.

The Asian-Pacific region led by Japan, China and South Korea is undergoing a rapid growth due to increased stroke cases and the implementation of rehabilitation programmes by the governments.

In Latin America there is a rise in the adoption of hospitals and pilot programs, whereas the Middle East and Africa is moderately incorporated through the rehabilitation clinics.

What are the challenges and restraining factors of the Soft Exosuit Market?

The soft exosuit market has a number of issues, which limit its expansion. The expensive nature of high-level rehabilitation exosuit means that patients and hospitals in less developed and middle-income countries do not have access to it, and reimbursement policies vary between healthcare systems.

There is also a lack of clinical validation, regulatory barriers and long-term safety and efficacy research that slows down adoption. Issues related to durability, maintenance of the device, and non-standard procedures of quality discourage more extensive acceptability by healthcare providers.

Also, there are complexities associated with the training of the clinicians and the patients and the competition offered by the traditional therapy and inflexible exoskeletons are challenges to increased penetration of rehabilitation programs in the global context.

Country-Wise Insights

United States leads healthcare soft exosuit adoption globally

The healthcare soft exosuit market is dominated by the United States because it boasts of good infrastructure in rehabilitation, considerable use in hospitals, and extensive investment in medical robotics. Stroke, spinal cord, and neurological disorders are also high in the country, and therefore the assistive mobility solutions have a great demand.

Faster integration of exosuits into therapy occurs through supportive efforts of veteran rehabilitation programs, clinical trials and research collaborations. Moreover, U.S. firms are the leaders in innovation and come up with lighter, AI-driven, and patient-friendly designs.

Even though high costs are still a deterrent, intense reimbursement initiatives coupled with modernization of healthcare are set to make the U.S. the biggest and most developed market in the world.

Japan drives growth with aging population and robotic healthcare

The healthcare soft exosuit market of Japan is driven by the fact that the aging population is growing at a rapid pace and that the government of Japan is in full support of robotics in relation to providing care and rehabilitation to the elderly. Having one of the highest proportions of the elderly in the world, the market of mobility-assist devices has a high demand.

Soft exosuits are actively used in hospitals and rehabilitation centers in Japan to recover after a stroke, gait training, and fall prevention. The culture of the early acceptance of technologies in Japan, as well as the efforts of the society to maintain the longevity and independent living, will guarantee the further growth. Clinical effectiveness is expanding the adoption although at a high cost.

Germany leads Europe in rehabilitation-focused soft exosuit adoption

Germany is the market leader in terms of healthcare soft exosuit in Europe that is backed by substantial research in medical robotics, healthcare funding, and infrastructure based on rehabilitation. There is a growing number of neurological disorder cases and the ageing population in the country which has led to the demand of assistive mobility device. Soft exosuits have been incorporated in German hospitals, rehabilitation centers, and geriatric centers to enhance therapy results and patient autonomy.

Innovation is promoted by the government by using R&D grants and partnerships between the academia, healthcare providers, and manufacturers. The domestic and European firms are busy launching advanced exosuits with increased efficiency and comfort. Germany has high patient awareness, and favorable health policies, which strengthens the position of the country as a growth engine.

Category-Wise Analysis

Lower body exosuits dominate rehabilitation for mobility recovery

Lower body soft exosuits prevail in the healthcare sector because they are essential in rehabilitation of stroke, spinal cord patients as well as multiple sclerosis patients. These exosuits are aimed at assisting movement, enhancing gait, and assisting muscle performance in the process of recovery.

The textile base facilitates their easy weight, which makes them comfortable and flexible as opposed to rigid exoskeletons, and persuades them to use them longer during therapy. Lower body suits have gained more and more popularity as a gait training and mobility aids in hospitals and rehabilitation centers, especially with elderly patients. As the need to get assistive walking solutions increases, this segment is the first to adopt and is projected to continue a high growth in the next few years.

Actuation technology leads with precise, adaptive patient assistance

The biggest portion of the healthcare soft exosuit market is the actuation technology, which provides a high level of accuracy with the help of sensors, motors, and intelligent materials that can recreate natural human movement. The systems improve muscle strength, fatigue level, and offer individual support to patients depending on their needs. Their lightweight actuators, AI algorithms, and responsive control systems enable them to be useful during the rehabilitation process, particularly when it comes to recovering walking skills after an injury or a stroke.

The exosutes made in the form of actuation are very popular in hospitals and therapy centers because of their flexibility and clinical effectiveness. Ongoing development of smaller actuators and power systems will lead to the further penetration of the segment and the enhancement of performance.

Rehabilitation remains the largest application driving healthcare adoption

The most widespread use of healthcare soft exosuits is rehabilitation, which is provided by the growing numbers of cases of neurological diseases, mobility disorders, and post-surgery rehabilitation requirements. Physiotherapy programs use soft exosuits to facilitate recovery of motor functions, increase gait patterns and increase patient independence.

They are lightweight and can be flexed in a way that enables them to train the patients in natural movements without causing discomfort hence they can be used in the long term therapy. Exosuits are being embraced by rehabilitation centers, hospitals, and clinics across the world as an adding additive to the traditional physiotherapy. As the population ages and the cases of stroke increase, rehabilitation usage will continue to dominate and lead the healthcare soft exosuit market in the fastest growth.

Competitive Analysis

Key players in the soft exosuit market include SuitX (Ottobock), ReWalk Robotics Ltd., Ekso Bionics Holdings Inc., CYBERDYNE Inc., Myomo Inc., B-Temia, Bioservo Technologies AB, ExoAtlet, Wearable Robotics Srl

The soft exosuit market has been very competitive because of the technology innovation, clinical validation and patient focus design. Several companies, including Harvard Wyss Institute spin-offs, ReWalk Robotics, Ekso Bionics and Bioservo Technologies, are concentrating on lightweight, textile exosuits to decrease the level of mobility, rehabilitation and comfort of the patients. Competitive strategies involve collaboration with hospitals, rehabilitation centres and research centres to prove clinical efficacy and increase adoption.

Businesses focus on durability, ergonomical fit, and flexibility at the point of inclusion in therapy programs. Their additional positioning in terms of pilot programs, insurance reimbursement programs, and personalized using smart sensors also enhances their position, and they will be differentiated in the dynamic landscape of market assistive robotics.

Recent Development

• In December 2023, Singapore-based SingHealth Community Hospitals collaborated with ArmasTec to create the AEGIS Exosuit, which is a wearable device that can protect healthcare personnel more and minimize the risk of injury. The project is dedicated to the development of a soft exosuit that will facilitate physically challenging situations and enhance the level of safety of workers and fatigue reduction in the healthcare environment.
• In February 2025, Researchers at the University of Notre Dame introduced a new robotic exosuit, which is driven by air-filled and soft actuators. These are actuators that replicate natural muscle actions, and they are light-weight and comfortable. The design demonstrates how soft actuators can substitute conventional motors, which offers a more conformal and non-invasive interface with the human body that has the potential to transform wearable robotics to rehabilitation and mobility support.

Fact.MR has provided detailed information about the price points of key manufacturers of Soft Exosuit Market positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Methodology and Industry Tracking Approach

The soft exosuit market technique used a combination of primary and secondary research in order to have a strong analysis. An example of a survey that was carried out on 4,000 people in 12 key countries comprised healthcare workers, physiotherapists, rehabilitation facilities, hospitals, and patients (70 percent of respondents), with 30 percent of the remaining respondents being industry stakeholders, including device manufacturers, suppliers, and insurers. These included adoption trends, reimbursement scenario, technology acceptance, pricing and distribution channel in the period of September 2024 to August 2025. More than 100 secondary sources were analyzed such as clinical studies, regulatory filings, company reports, and patents. Validation of the forecasts was carried out by the extrapolation of trends, regression model, and the analysis of scenarios, which guaranteed an accurate market forecasting.

With Fact.MR monitoring consumer behavior, product efficacy, industry trends, and market opportunities since 2018, this report is becoming an authoritative source of information that stakeholders can rely on.